Nutriband Inc (NTRB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $74.15M
Last updated: Nov 17, 2026 at 11:03 AM ET
Nutriband Inc (NTRB) Financials: Revenue, Profit and Cash Flow
Nutriband reported revenue of $2.04M for the fiscal year ended Jan 31, 2026, down 4.8% from the year before. That year, net income was -$8.23M with a net margin of -404.1%, operating cash flow was -$5.13M and free cash flow was -$5.14M. The quarter ended Jul 31, 2026 had revenue of $437.51K and net income of -$880.56K.
Revenue and Margins
Over the 7 years to Jan 2026, revenue grew from $245.28K, a compound annual rate of 35.3%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Jan 2026 | $2.04M | -4.8% | 27.8% | -408.4% | -404.1% |
| Jan 2025 | $2.14M | +2.6% | 34.7% | -480.7% | -489.9% |
| Jan 2024 | $2.09M | +0.3% | 41.3% | -233.6% | -263.0% |
| Jan 2023 | $2.08M | +46.2% | 36.1% | -215.2% | -215.6% |
| Jan 2022 | $1.42M | +50.7% | 35.5% | -429.7% | -434.3% |
| Jan 2021 | $943.70K | +154.6% | 33.5% | -275.1% | -310.8% |
| Jan 2020 | $370.65K | +51.1% | -48.1% | -531.4% | -734.3% |
| Jan 2019 | $245.28K | N/A | -17.5% | -1358.1% | -1358.1% |
| Jan 2018 | $0 | N/A | N/A | N/A | N/A |
| Jan 2017 | $0 | N/A | N/A | N/A | N/A |
Income Statement
In the fiscal year ended Jan 2026, the net loss narrowed from the year before. In the quarter ended Jul 2026, the net loss narrowed from the same quarter a year earlier.
Annual
| Line item | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.04M | $2.14M | $2.09M | $2.08M | $1.42M | $943.70K | $370.65K | $245.28K | $0 | $0 |
| Cost of revenue | $1.47M | $1.40M | $1.22M | $1.33M | $917.84K | $627.38K | $549.11K | $288.30K | $0 | $0 |
| Gross profit | $566.31K | $743.32K | $862.11K | $750.41K | $504.31K | $316.32K | -$178.46K | -$43.02K | $0 | $0 |
| Research and development | $1.89M | $3.12M | $1.96M | $982.23K | $411.38K | $0 | $0 | $0 | $0 | $0 |
| Operating income | -$8.32M | -$10.28M | -$4.87M | -$4.48M | -$6.11M | -$2.60M | -$1.97M | -$3.33M | -$2.67M | -$151.26K |
| Net income | -$8.23M | -$10.48M | -$5.49M | -$4.48M | -$6.18M | -$2.93M | -$2.72M | -$3.33M | -$2.67M | -$151.26K |
| EBITDA | -$8.12M | -$10.00M | -$4.58M | -$4.15M | -$5.69M | -$2.21M | N/A | -$3.29M | -$2.67M | -$151.26K |
Quarterly
| Line item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $437.51K | $433.40K | $400.71K | $346.06K | $622.45K | $667.43K | $642.38K | $645.80K | $442.83K | $408.53K | $524.61K | $427.84K |
| Gross profit | $181.87K | $196.80K | $88.94K | $68.50K | $156.88K | $251.98K | $274.62K | $191.03K | $101.56K | $164.79K | $181.23K | $158.92K |
| Operating income | -$890.64K | -$1.25M | -$1.02M | -$3.88M | -$2.00M | -$1.41M | -$1.96M | -$1.43M | -$1.41M | -$1.89M | -$1.31M | -$1.72M |
| Net income | -$880.56K | -$1.24M | -$968.06K | -$3.87M | -$2.00M | -$1.39M | -$5.52M | -$1.36M | -$1.71M | -$1.90M | -$1.88M | -$1.76M |
Balance Sheet
As of Jan 2026, cash and equivalents exceeded total debt of $164.73K by $4.41M.
Annual
| Line item | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $7.55M | $7.47M | $7.52M | $9.46M | $12.74M | $9.93M | $2.20M | $2.81M | $164.90K | $37.73K |
| Current assets | $4.99M | $4.79M | $1.02M | $2.69M | $5.47M | $314.19K | $43.18K | $590.47K | $164.90K | $37.73K |
| Cash and equivalents | $4.57M | $4.31M | $492.94K | $1.99M | $4.89M | $151.99K | $10.18K | $474.65K | $0 | $27.12K |
| Total liabilities | $868.45K | $1.04M | $1.08M | $883.39K | $880.38K | $2.82M | $2.02M | $403.01K | $43.39K | $14.62K |
| Short-term debt | $128.87K | $128.14K | $127.18K | $19.74K | $14.12K | $1.52M | $311.57K | $40.00K | $16.82K | $1.58K |
| Long-term debt | $35.86K | $58.20K | $79.83K | $100.50K | $101.12K | $150.06K | $0 | $0 | $0 | $0 |
| Shareholder equity | $6.68M | $6.43M | $6.44M | $8.57M | $11.86M | $7.11M | $175.43K | $2.40M | $121.51K | $23.11K |
Quarterly
| Line item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $6.29M | $6.89M | $7.55M | $8.42M | $10.18M | $6.15M | $7.47M | $12.54M | $13.63M | $15.15M | $7.52M | $8.52M |
| Total liabilities | $964.36K | $902.31K | $868.45K | $870.21K | $1.68M | $1.05M | $1.04M | $1.31M | $1.17M | $1.79M | $1.08M | $2.81M |
| Cash and equivalents | $3.42M | $4.01M | $4.57M | $5.31M | $7.00M | $2.96M | $4.31M | $5.70M | $6.76M | $8.35M | $492.94K | $1.27M |
| Shareholder equity | $5.33M | $5.99M | $6.68M | $7.55M | $8.49M | $5.10M | $6.43M | $11.23M | $12.46M | $13.36M | $6.44M | $5.71M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Jan 2026.
Annual
| Line item | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$5.13M | -$4.63M | -$3.53M | -$2.99M | -$2.81M | -$297.06K | -$894.47K | -$1.11M | -$92.86K | -$147.92K |
| Capital expenditures | $5.32K | $92.04K | $51.76K | $79.30K | $81.59K | $0 | $81.59K | $4.16K | $4.16K | $4.16K |
| Free cash flow | -$5.14M | -$4.72M | -$3.58M | -$3.07M | -$2.89M | -$297.06K | -$976.07K | -$1.11M | -$97.02K | -$152.09K |
| Dividends paid | N/A | N/A | N/A | $296.88K | $196.59K | N/A | N/A | $0 | $2.50M | $0 |
| Share repurchases | $0 | $148.55K | $0 | $119.01K | $104.47K | $0 | N/A | N/A | N/A | N/A |
| Investing cash flow | -$5.32K | -$92.04K | -$51.76K | -$79.30K | -$81.59K | $66.99K | $0 | -$404.16K | $0 | $0 |
| Financing cash flow | $5.40M | $8.54M | $2.09M | $160.07K | $7.63M | $371.87K | $430.25K | $1.98M | $65.76K | $174.90K |
Quarterly
| Line item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$585.00K | -$563.10K | -$731.83K | -$1.75M | -$1.31M | -$1.34M | -$1.24M | -$1.01M | -$1.63M | -$833.93K | -$718.24K | -$431.60K |
| Capital expenditures | N/A | $0 | $5.32K | $3 | $5.32K | $5.32K | $4 | $46.96K | $42.46K | $6.20K | $49.14K | $42.46K |
| Free cash flow | N/A | -$563.10K | -$737.15K | -$1.75M | -$1.32M | -$1.34M | -$1.24M | -$1.06M | -$1.67M | -$840.12K | -$767.38K | -$474.06K |
Frequently Asked Questions About NTRB
What is Nutriband's annual revenue?
Nutriband reported revenue of $2.04M for the fiscal year ended Jan 31, 2026.
How fast is Nutriband's revenue growing?
Revenue was down 4.8% for the fiscal year ended Jan 31, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was -0.7%.
Is Nutriband profitable?
No. Nutriband reported net income of -$8.23M for the fiscal year ended Jan 31, 2026, with a net margin of -404.1%.
How much free cash flow does NTRB generate?
For the fiscal year ended Jan 31, 2026, operating cash flow of -$5.13M minus capital expenditures of $5.32K produced free cash flow of -$5.14M.
How much debt does Nutriband have?
The balance sheet dated Jan 31, 2026 reported long-term debt of $35.86K, short-term debt of $128.87K and cash and equivalents of $4.57M.
NTRB pages: Overview, Earnings, Financials, Valuation, Competitors